Genetic Technologies Limited (GTG.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 6.18 Million AUD | -58.36% |
| 2023 | 14.85 Million AUD | -28.58% |
| 2022 | 20.8 Million AUD | -9.45% |
| 2021 | 22.97 Million AUD | 46.94% |
| 2020 | 15.63 Million AUD | 378.8% |
| 2019 | 3.26 Million AUD | -47.05% |
| 2018 | 6.16 Million AUD | -49.08% |
| 2017 | 12.1 Million AUD | -8.89% |
| 2016 | 13.28 Million AUD | -35.86% |
| 2015 | 20.71 Million AUD | 207.91% |
| 2014 | 6.72 Million AUD | -19.12% |
| 2013 | 8.31 Million AUD | -49.4% |
| 2012 | 16.44 Million AUD | 84.28% |
| 2011 | 8.92 Million AUD | 7.76% |
| 2010 | 8.27 Million AUD | -62.83% |
| 2009 | 22.27 Million AUD | -7.75% |
| 2008 | 24.14 Million AUD | 15.25% |
| 2007 | 20.95 Million AUD | -6.64% |
| 2006 | 22.44 Million AUD | -23.31% |
| 2005 | 29.26 Million AUD | 30.71% |
| 2004 | 22.38 Million AUD | -25.97% |
| 2003 | 30.24 Million AUD | -8.35% |
| 2002 | 33 Million AUD | -16.84% |
| 2001 | 39.68 Million AUD | 348.58% |
| 2000 | 8.84 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 6.18 Million AUD | 0.0% |
| 2024 Q2 | 8.46 Million AUD | 0.0% |
| 2024 FY | 6.18 Million AUD | -58.36% |
| 2023 Q2 | 15.69 Million AUD | 0.0% |
| 2023 FY | 14.85 Million AUD | -28.58% |
| 2023 Q4 | 14.85 Million AUD | 0.0% |
| 2022 Q1 | 22.54 Million AUD | -1.87% |
| 2022 FY | 20.8 Million AUD | -9.45% |
| 2022 Q3 | 20.8 Million AUD | -7.72% |
| 2022 Q4 | 20.8 Million AUD | 0.0% |
| 2022 Q2 | 22.54 Million AUD | 0.0% |
| 2021 Q2 | 18.84 Million AUD | 0.0% |
| 2021 FY | 22.97 Million AUD | 46.94% |
| 2021 Q3 | 22.97 Million AUD | 21.91% |
| 2021 Q4 | 22.97 Million AUD | 0.0% |
| 2020 FY | 15.63 Million AUD | 378.8% |
| 2020 Q2 | 4.34 Million AUD | 0.0% |
| 2020 Q4 | 15.63 Million AUD | 0.0% |
| 2019 FY | 3.26 Million AUD | -47.05% |
| 2019 Q2 | 4.11 Million AUD | 0.0% |
| 2019 Q4 | 3.26 Million AUD | 0.0% |
| 2018 FY | 6.16 Million AUD | -49.08% |
| 2018 Q2 | 8.54 Million AUD | 0.0% |
| 2018 Q4 | 6.16 Million AUD | 0.0% |
| 2017 Q4 | 12.1 Million AUD | 0.0% |
| 2017 FY | 12.1 Million AUD | -8.89% |
| 2017 Q2 | 16.47 Million AUD | 0.0% |
| 2016 Q2 | 17.21 Million AUD | 0.0% |
| 2016 FY | 13.28 Million AUD | -35.86% |
| 2016 Q4 | 13.28 Million AUD | 0.0% |
| 2015 Q2 | 3.45 Million AUD | 0.0% |
| 2015 FY | 20.71 Million AUD | 207.91% |
| 2015 Q4 | 20.71 Million AUD | 0.0% |
| 2014 Q4 | 6.72 Million AUD | 0.0% |
| 2014 Q2 | 15.19 Million AUD | 0.0% |
| 2014 FY | 6.72 Million AUD | -19.12% |
| 2013 Q3 | 8.31 Million AUD | -35.31% |
| 2013 FY | 8.31 Million AUD | -49.4% |
| 2013 Q2 | 12.86 Million AUD | 0.0% |
| 2013 Q4 | 8.31 Million AUD | 0.0% |
| 2012 FY | 16.44 Million AUD | 84.28% |
| 2012 Q2 | 16.14 Million AUD | 0.0% |
| 2012 Q4 | 16.44 Million AUD | 0.0% |
| 2011 Q2 | 12.46 Million AUD | 0.0% |
| 2011 FY | 8.92 Million AUD | 7.76% |
| 2011 Q4 | 8.92 Million AUD | 0.0% |
| 2010 FY | 8.27 Million AUD | -62.83% |
| 2010 Q4 | 8.27 Million AUD | 0.0% |
| 2010 Q2 | 12.71 Million AUD | 0.0% |
| 2009 Q2 | 22.17 Million AUD | 0.0% |
| 2009 Q4 | 17.97 Million AUD | 0.0% |
| 2009 FY | 22.27 Million AUD | -7.75% |
| 2008 Q2 | 28.51 Million AUD | 0.0% |
| 2008 Q4 | 24.14 Million AUD | 0.0% |
| 2008 FY | 24.14 Million AUD | 15.25% |
| 2007 Q4 | 20.95 Million AUD | 0.0% |
| 2007 FY | 20.95 Million AUD | -6.64% |
| 2007 Q2 | 29 Million AUD | 0.0% |
| 2006 Q2 | 38.7 Million AUD | 0.0% |
| 2006 FY | 22.44 Million AUD | -23.31% |
| 2006 Q4 | 22.44 Million AUD | 0.0% |
| 2005 FY | 29.26 Million AUD | 30.71% |
| 2005 Q4 | 29.26 Million AUD | 0.0% |
| 2005 Q2 | 21.81 Million AUD | 0.0% |
| 2004 FY | 22.38 Million AUD | -25.97% |
| 2003 FY | 30.24 Million AUD | -8.35% |
| 2002 FY | 33 Million AUD | -16.84% |
| 2001 FY | 39.68 Million AUD | 348.58% |
| 2000 FY | 8.84 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Australian Clinical Labs Limited | 593.06 Million AUD | 98.957% |
| BCAL Diagnostics Limited | 12.26 Million AUD | 49.562% |
| Genetic Signatures Limited | 67.28 Million AUD | 90.806% |
| Healius Limited | 2.98 Billion AUD | 99.793% |
| Imagion Biosystems Limited | 4.58 Million AUD | -34.892% |
| Integral Diagnostics Limited | 744.27 Million AUD | 99.169% |
| INOVIQ Ltd | 21.7 Million AUD | 71.498% |
| Microba Life Sciences Limited | 58.04 Million AUD | 89.341% |
| Monash IVF Group Limited | 508.47 Million AUD | 98.783% |
| Rhythm Biosciences Limited | 1.51 Million AUD | -307.354% |
| Sonic Healthcare Limited | 14.82 Billion AUD | 99.958% |